个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

The CRISPR-Cas system in molecular diagnostics

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Song Rao[1] * ; Chen Zhongyi[2] * ; Xiao Hongtao[1] ; Wang Haojun[2] ;
机构： [1]Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China. [2]Department of Pathology, Suining Central Hospital, Suining 629000, China
出处：
DOI： 10.1016/j.cca.2024.119820
ISSN：

关键词： CRISPR Detection Molecular diagnosis Biosensor Cas9 Cas12 Cas13 COVID-19

摘要：
Robust, sensitive, and rapid molecular detection tools are essential prerequisites for disease diagnosis and epidemiological control. However, the current mainstream tests necessitate expensive equipment and specialized operators, impeding the advancement of molecular diagnostics. The CRISPR-Cas system is an integral component of the bacterial adaptive immune system, wherein Cas proteins recognize PAM sequences by binding to CRISPR RNA, subsequently triggering DNA or RNA cleavage. The discovery of the CRISPR-Cas system has invigorated molecular diagnostics. With further in-depth research on this system, its application in molecular diagnosis is flourishing. In this review, we provide a comprehensive overview of recent research progress on the CRISPR-Cas system, specifically focusing on its application in molecular diagnosis.Copyright © 2024 Elsevier B.V. All rights reserved.

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类 | 3 区 医学
小类 | 3 区 医学实验技术
JCR分区：
出版当年[2024]版：
无
最新[2023]版：
Q2 MEDICAL LABORATORY TECHNOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者：
第一作者机构： [1]Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Song Rao,Chen Zhongyi,Xiao Hongtao,et al.The CRISPR-Cas system in molecular diagnostics[J].Clinica Chimica Acta; International Journal Of Clinical Chemistry.2024,561:119820.doi:10.1016/j.cca.2024.119820.
APA：
Song Rao,Chen Zhongyi,Xiao Hongtao&Wang Haojun.(2024).The CRISPR-Cas system in molecular diagnostics.Clinica Chimica Acta; International Journal Of Clinical Chemistry,561,
MLA：
Song Rao,et al."The CRISPR-Cas system in molecular diagnostics".Clinica Chimica Acta; International Journal Of Clinical Chemistry 561.(2024):119820

相关文献

[1]CRISPR-Cas13a cascade-based viral RNA assay for detecting SARS-CoV-2 and its mutations in clinical samples. [2]CRISPR Cas9-Mediated Selective Isothermal Amplification for Sensitive Detection of Rare Mutant Alleles. [3]四川省南充市16例新型冠状病毒感染患者就医行为分析 [4]Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19. [5]rAAV-CRISPR/Cas9-mediated in vivo delivery of porcine embryos to construct knockout pigs [6]Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis [7]Developing pioneering pharmacological strategies with CRISPR/Cas9 library screening to overcome cancer drug resistance [8]Characteristics, Recombination methods and Applications progresses of Split-Cas9 System [9]RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. [10]Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation

资源点击量：53080 今日访问量：0 总访问量：4588 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号